Figure 7From: In vitro activities of novel 4-HPR derivatives on a panel of rhabdoid and other tumor cell linesInhibition of breast cancer cell growth by 4-HPR and its derivatives and peptidomimetics. A. Immunoblot analysis to determine the levels of Cyclin D1 protein expression in the breast cancer cell lines tested compared to MON RT cells. B and C. Survival curves of MCF7 (B) and MDAMB231 (C) cells treated for three days with increasing concentrations of ATRA, 4-HPR, and 4-HPR derivatives and peptidomimetics.Back to article page